Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2047-9158
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease ; volume:11 ; number:1 ; day:10 ; month:2 ; year:2022 ; pages:1-26 ; date:12.2022
Translational neurodegeneration ; 11, Heft 1 (10.2.2022), 1-26, 12.2022
- Urheber
-
Jakova, Elisabet
Moutaoufik, Mohamed Taha
Lee, Jeremy S.
Babu, Mohan
Cayabyab, Francisco S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40035-022-00284-3
- URN
-
urn:nbn:de:101:1-2022051618515237950655
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 05:34 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jakova, Elisabet
- Moutaoufik, Mohamed Taha
- Lee, Jeremy S.
- Babu, Mohan
- Cayabyab, Francisco S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Models of α-synuclein aggregation in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Increased immune activation by pathologic α‐synuclein in parkinson's disease
Increased immune activation by pathologic α‐synuclein in Parkinson's disease
α-Synuclein [Alpha-Synuclein] : synaptische Funktion und Rolle bei der Pathogenese der Parkinson-Syndrome
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Models of α-synuclein aggregation in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Increased immune activation by pathologic α‐synuclein in parkinson's disease
Increased immune activation by pathologic α‐synuclein in Parkinson's disease
α-Synuclein [Alpha-Synuclein] : synaptische Funktion und Rolle bei der Pathogenese der Parkinson-Syndrome
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Models of α-synuclein aggregation in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Increased immune activation by pathologic α‐synuclein in parkinson's disease
Increased immune activation by pathologic α‐synuclein in Parkinson's disease
α-Synuclein [Alpha-Synuclein] : synaptische Funktion und Rolle bei der Pathogenese der Parkinson-Syndrome
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease